1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)-cyclopropanecarboxylic acid, 95.0%, 100g

4-Oxo-4-thiophen-2-yl-butyric acid ethyl ester, 5g

Tert-butyl 1-(hydroxymethyl)-8-azaspiro[4.5]decane-8-carboxylate, 98%, 250mg

tert-Butyl 3-(6-bromoimidazo[1,5-a]pyridin-1-yl)azetidine-1-carboxylate, 95+%, 250mg

methyl 3-acetyl-1H-indole-5-carboxylate, 95.0%, 500mg

Methyl 2-azabicyclo[2.2.2]octane-4-carboxylate hydrochloride, 98%, 1g

2-Bromo-4-chlorobenzonitrile, 98.0%, 10g

1,1,1,2,4,4,5,7,7,8,10,10,11,13,13,14,14,15,15,15-Icosafluoro-5,8,11-tris(trifluoromethyl)-3,6,9,12-tetraoxapentadecane>92.0%(GC)25g

2-Amino-2-(2,3-dimethoxyphenyl)acetic acid, 98%, 1g

methyl 5-bromo-6-fluoro-1H-indole-3-carboxylate, 95.0%, 100mg

[3-(1-pyrrolidin-1-ylethyl)phenyl]boronic acid, 95.0%, 1g

Wide mouth bottle ROTILABO® Without UN approval, 350 ml, 45 mm, 10 Piece(s)

ETHYL 2-(4-BROMOPYRIDIN-2-YL)ACETATE, 95.0%, 250mg